Acacia: Physical and chemical tests / Analysis of crude drugs
Aim:
To identify the chemical characteristics of a given sample.
Constituents:
Gum Arabic consists almost entirely of glycosidic acid named Arabic acid, combined with potassium, magnesium and calcium. By hydrolysis Arabic acid yields 1 molecule of l-rhamnose, 2 molecules of D – galactose and 3 molecules of l– arabinose and an aldobionic acid. It also contains diastase and an oxidase enzyme.
PROCEDURE :
- Dissolve about 0.25 gm of the coarsely powdered drug in 5 ml of distilled water by shaking in the cold. Add 0.5 ml of hydrogen peroxide and 0.5 ml of benzidine solution, shake and allow to stand for a few minutes; a deep blue colour or greenish-blue colour is formed due to the presence of oxidase enzyme.
- A 10% aqueous solution of acacia fails to produce any precipitate with a dilute solution of lead acetate (a clear distinction from Agar and Tragacanth); it does not give any colour change with Iodine solution (a marked distinction from starch and dextrin), and it never produces a bluish-black colour with FeCl3 solution (an apparent distinction from tannins).
- Hydrolysis of an aqueous solution of acacia with dilute HCl yields reducing sugars whose presence is ascertained by boiling with Fehling’s solution to give a brick-red precipitate of cuprous oxide
CONCLUSION
The above morphological characteristics and chemical tests indicate that the crude drug is Acacia.
REFERENCES
Kokate CK. Practical Pharmacognosy, 4 edition, VallabhPrakashan. Delhi; 1994: 98
F Y D Pharm & S Y D Pharm Notes, Books, Syllabus, PDF, Videos
Second Year B Pharm Notes, Syllabus, Books, PDF Subjectwise/Topicwise
Suggested readings
Recommended readings:
- Hepatitis
- b pharmacy syllabus
- Pharmaceutics I Theory
- Pharmaceutical Analysis I Theory
- Pharmaceutics I Practical
- Computer Applications in Pharmacy Practical
Marburg Virus Disease: A Severe, Often Fatal Illness
Performance Monitoring and Updates in AI-Enabled Medical Devices: FDA’s Guiding Principles
Lifecycle Management in AI-Enabled Medical Devices: FDA’s Comprehensive Framework